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Abstract cDNA clones of the mouse GM2/GD2 synthase (EC 
2.4.1.92) gene were isolated, and their analyses revealed that the 
protein has a type II transmemhrane structure with 533 amino 
acids, which was very similar to the human homolog except for 
the mRNA size. The mRNA level in thymocytes dramatically 
increased after treatment with anti-CD3 monoclonal antibody, 
whereas it was not elevated when treated with prostaglandin E2. 
In situ hybridization showed an elevation of mRNA levels in 
medullar thymocytes, suggesting that T cell receptor-mediated 
signaling induces up-regulation of the GM2/GD2 synthase gene 
in mature thymocytes. 
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1. Introduction 
Gangliosides have been studied as cellular receptors for tox- 
ins and viruses [I]. They are considered to be receptors for 
celllcell or celllextracellular matrix interactions, and modula- 
tors of receptors for cell growth factors [2]. They have also been 
analyzed as tumor specific antigens [3,4]. In normal tissues, 
gangliosides are abundant in brain tissues [l], and are also 
found in immune cells [5-71. The lines of evidence have sug- 
gested that gangliosides on mouse lymphocytes are associated 
with their functional properties and play important roles in 
immunological reactions. However, the genetic control of these 
gangliosides is not well understood yet. 
In the present study, we isolated cDNAs for the mouse GM21 
GD2 synthase (EC 2.4.1.92) gene in order to analyze the regu- 
lation of the ganglioside synthesis in mouse immune cells. Since 
many gangliosides are synthesized via GM2 or GD2, the ex- 
pression of this gene seemed critical for the metabolism of the 
major gangliosides. Alterations of mRNA levels and the en- 
zyme activity in mouse thymocytes after stimulation with anti- 
CD3 monoclonal antibody (mAb) and prostaglandin E2 
(PGE2) were analyzed. These results suggest that GM2/GD2 
*Corresponding author. Fax: (81) (958) 49 3695. 
The nucleotide sequence(s) reported in this paper has been submitted 
to the GenBank/EMBL Data Bank with accession number(s) L25885. 
Abbreviations: mAb, monoclonal antibody; IF, immunofluorescence; 
kbp(s), kilobasepair(s); PGE2, prostaglandin E2. Ganglioside nomen- 
clature is based on that of Svennerholm [36]: GM2, GalNAc/I1+4 
(NeuAca2-+3) Gal/II +4 Glc-Cer; GD2, GalNAcBl+4 (Neu- 
Accz2+8NeuAca2+3) Gal/I1+4 Glc-Cer. 
synthase is regulated at both gene transcriptional and epigen- 
etic levels. 
2. Materials and methods 
2.1. Construction oj’cDNA expression libruries 
A cDNA prepared from poly(A)’ RNA of the mouse thymoma cell 
line EL4 was a gift from Dr. T. Taniguchi of Osaka University. The 
&XI adaptor was added to the cDNA, which was then ligated into the 
BstXI site of the expression vector pCDM8 [8]. The library contained 
2 x 10’ independent colonies. 
2.2. cDNA cloning und DNA sequencing 
Transformed colonies were screened by replica plating method ac- 
cording to Hanahan and Meselson [Y], using a labeled I .3 kbp SmaI 
EcoRI fragment of the human GM2/GD2 synthase clone pMZTl--1 [lo] 
as a probe. The membranes were hybridized and washed at 60°C. 
Plasmid DNA from hybridization-positive clones was transfected into 
KF3027 cells using DEAE dextran [IO]. After 64-72 h. GM2 expression 
was examined by the immunofluorescence (IF) assay using mAb IO-I 1 
as described [IO]. Positive clones were classified based on their cleavage 
profiles with EeoRI, BamHI, HindHI, Xhol and SulI endonucleases. 
Overlapping deletion subclones were constructed as previously de- 
scribed [IO] in pUCl9 in which the cDNA insert had been bidirectionaly 
subcloned. Sequencing was performed as described [IO] by using a 
reverse primer. 
2.3. Cell lines and tissues 
B78 and KF3027 were mouse melanoma lines as reported [IO]. 
MeWo was a human melanoma line provided by Dr. L.J. Old (Sloan- 
Kettering Cancer Center, New York). Mouse melanoma line JB-RH 
was given by Dr. P. Livingston (Sloan-Kettering Cancer Center). CMS- 
7 was a mouse fibrosarcoma line. WOP-3027 was a mouse fibroblast 
line provided by Dr. B Seed (Harvard University). NG108815 was a 
mouse-rat hybrid line kindly given by Dr. A. Miyazaki in Tokyo Uni- 
versity. They were cultured in Dulbecco’s modified Eagle’s minimal 
essential medium (D-MEM) supplemented with 10% fetal bovine 
serum. 
2.4. Antibodies and,jow cytometry 
Anti-GM2 mAb 10~11 [ll] was a gift from Dr. P. Livingston in 
Sloan-Kettering Cancer Center. A hamster anti-CD3 mAb (14552Cll) 
was provided by Dr. J.A. Bluestone, University of Chicago as reported 
previously [12]. Expression of gangliosides were analyzed with a 
FACScan (Becton-Dickinson) as previously described [lo]. 
2.5. Treatment of thymoeytes in culture 
Thymocytes from 4- to 6-week-old male BALB/c mice were prepared 
and cultured at a density of 2.5 x lO’/ml in RPM1 1640 medium supple- 
mented with 10% fetal calf serum, 0.05 mM 2-mercaptoethanol. They 
were exposed to the anti-CD3 mAb at a dilution of 1: 1000 or to 0.1 PM 
PGE2 for I-12 h. PGE2 (Sigma) was dissolved in 95% ethanol and 
stored at -20°C. 
2.6. Northern blotting 
Total RNA and poly(A)’ RNA from thymocytes and cell lines were 
prepared as described [10,13]. Separation and blotting of RNA were 
performed as described [IO]. The membrane was prehybridized for 6 h 
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Fig. 1. Deduced amino acid sequence of the mouse GM2/GD2 synthase cDNA clone pTm3-5. The amino acid sequence of human GM2/GD2 synthase 
is presented for comparison. The transmembrane domain is marked by a square. Potential N-glycosylation sites are underlined. Dots represent 
identical amino acids 
and hybridized with an XbaI fragment containing 2.1 kbp of mouse 
cDNA labeled by a random priming kit (Amersham) at 42°C for 12 h. 
The membrane was washed and exposed to a film as described [lo]. The 
mouse 28 S tRNA-specific plasmid I-19/BS was provided by Dr. K. Abe 
(Kumamoto University, Kumamoto, Japan) and used as a control 
probe to correct for the amount of the applied RNA. 
2.7. GMZIGDZ synthase assay 
The membrane fraction of thymocytes were prepared as described by 
Thampoe et al. [14]. The emzyme assay was performed by duplicate 
samples as previously described [ 151. 
2.8. Treatment of mice with anti-CD3 mAb in vivo 
Four- to six-week-old male BALBlc mice were administered with 25 
~1 of ascites containing anti-CD3 mAb diluted in 175 ~1 of D-MEM 
intravenously, then sacrificed at the indicated times. Thymuses were 
embedded in O.C.T. compound and rapidly frozen on dry ice. 
2.9. Preparation of RNA probes for in situ hybridization 
Mouse GM2/GD2 synthase cDNA (pTm3-5) was transcribed from 
the T3 or T7 RNA polymerase promoters of Bluescript II KS (Strat- 
agene) to yield sense or antisense probes. The transcription reactions 
in 25 ~1 contained 1 pug of linearized template DNA, 40 mM Tris-HCl 
(pH 8.0) 8 mM MgCl,, 2 mM spermidine, 50 mM NaCl, 30 mM 
dithiothreitol, 10 U of RNase inhibitor (Takara Shuzo), 1 mM each of 
ATP, CTP and GTP, 0.65 mM UTP, 0.4 mM digoxigenin-labeled UTP 
(Boehringer Mannheim) and 20 U of T3 or T7 RNA polymerase (Strat- 
agene). The RNA probes were degraded by alkaline hydrolysis to an 
average length of 150 nucleotides [16]. 
2.10. In situ hybridization 
In situ hybridization of mRNA in thymus was performed as previ- 
ously described [17]. Hybridization proceeded at 60°C for 12-16 h in 
hybridization buffer containing 2.5 &ml of digoxigenin-labeled ribo- 
probes. After washing and blocking, the slides were incubated with 
sheep anti-digoxigenin Fab-fragments conjugated to alkaline phosphat- 
ase (Boehringer Mannheim). Finally, the slides were incubated with the 
substrate, then mounted with PermaFluor (Lipshaw, Detroit, MI). 
3. Results 
3.1. Isolation and characterization of mouse GM2lGD2 synthase 
cDNAs 
Approximately 2 x IO6 independent recombinants from the 
B 10 Mew0 
Relative log fluorescence 
Fig. 2. GM2 expression on mouse B78 and human MeWo cell lines 
transfected with pTm3-5. Transient transfection and flow cytometry of 
GM2 expression were performed as described in Materials and Meth- 
ods. Bold lines indicate the profile of the controls stained with FITC- 
conjugated goat anti-mouse IgM alone. A and B, transfection with 
vector alone. C and D, transfection with pTm3-5. 
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Fig. 3. Northern blots of various cell lines. Poly(A)’ mRNA (10 pg) 
from 5 cell lines was separated in a 1.25% agarose-formaldehyde gel, 
then hybridized with a ‘2P-labeled pTm335 insert probe. The mRNAs 
were derived from EL4 (lane 1). JB-RH (lane 2), CMS-7 (lane 3) 
NG108-15 (lane 4) and WOP-3027 (lane 5). Ethidium bromide staining 
of the gel is shown at the bottom. 
EL4 cDNA library were screened and thirty one hybridization 
positive clones were isolated, then transfected into KF3027 
cells. Twelve GMZ-positive clones containing a ~1.5 kb insert 
were placed into 5 groups based on their cleavage profiles with 
several endonucleases. Clone pTm3-5, one of the major group 
was characterized in detail. 
3.2. Nucleotide sequence and predicted amino acid sequence 
The complete nucleotide sequence of clone pTm3-5 (2,118 
bp) was determined and revealed that a continuous open read- 
ing frame of 1599 bp (533 amino acids) was present with no poly 
A signal or poly A tail. The sequence homology with the human 
cDNA” [lo] was 84.8% and 86.9% at the nucleotide and the 
amino acid level, respectively (Fig. 1). Inspection and a hy- 
dropathy analysis [18] of the predicted protein sequence sug- 
gested that it has a similar structural organization to those of 
known glycosyltransferases [19,20]. There is a single hydropho- 
bic segment (18 amino acids) near the amino terminus. Three 
potential sites for N-linked glycosylation were also found at the 
identical sites as in the human homolog. Flow cytometry re- 
vealed that both B78 and MeWo transiently transfected with 
pTm335 expressed high levels of GM2 (Fig. 2). 
3.3. Expression of GMZIGD2 synthase mRNA in cell lines 
Northern blotts with poly(A)’ RNA from mouse-derived 
cells revealed a major mRNA band at 2.7 kb and additional 3.4 
kb band as shown in Fig. 3. No high molecular weight mRNA 
as found in human cells [lo] was detectable. 
3.4. Expression of mouse Gh42iGD2 synthase gene and enzyme 
activity in thymocytes stimulated with anti-CD3 mAb or 
PGE2 
Thymocytes cultured with anti-CD3 mAb showed an ele- 
*The original nucleotide sequence in this reference has been corrected 
(GenbankIEMBL Data Bank accession number M83651). 
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Fig. 4. Expression of GM2/GD2 synthase gene during the stimulation 
of thymocytes with PGE2 or anti-CD3 mAb. A, Northern blot of total 
RNA extracted from thymocytes cultured with PGE2 (left) or anti-CD3 
mAb (right). 40 pg of each RNA was separated and blotted as in Fig. 
3. The relative intensities of bands measured using a Bio-Imaging An- 
alyzer BAS 2000 (Fuji) were plotted in B after correction using the 28s 
rRNA bands as described in section 2. ??, samples treated with anti-CD3 
mAb. ??, PGEZ-treated samples. 
vated level of GM2/GD2 synthase mRNA 8 h after addition of 
the mAb. After 12 h, the mRNA level markedly increased (Fig. 
4). On the other hand, PGE2 induced a mild increase 12 h after 
stimulation. The enzyme activities in the thymocytes stimulated 
3ooo I 
2000 
1000 
0 10 20 
Time (h) 
Fig. 5. GM2/GD2 synthase activity in thymocytes incubated with 
PGE2 or anti-CD3 mAb. Thymocytes were treated as in Fig. 4, and 
their enzyme activities were measured as described in section 2. ??. 
PGE2 and ??, anti-CD3 mAb. 
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Fig. 6. Up-regulation of GM2/GD2 synthase mRNA in thymocytes treated with anti-CD3 mAb. mRNA expression was examined by in situ 
hybridization using the antisense RNA Drobe as described in section 2 (B,E). The sense RNA probe was used as a negative control (C). HE, 
hkmatoxylin-eosinstaining (A,D). m, mehulla; c, cortex. 
by these two reagents altered in a different manner as shown 
in Fig. 5. Although there was a mild increase of enzyme activity 
in both preparations at an early phase (4 h), only anti-CD3 
stimulation elevated it more after 12 h. 
3.5. mRNA expression of GM2iGD2 synthase gene in the 
thymus 
In situ hybridization of GM21GD2 synthase gene in thymus 
revealed that the expression was confined to the medulla and 
scarce in the cortex. When treated with anti-CD3 mAb, mRNA 
expression in the medulla increased markedly at 12 h as shown 
in Fig. 6. 
4. Discussion 
Levels of ganglioside synthases are strictly regulated in the 
development of the brain as reported by Yu et al. [21]. Changes 
of gangliosides on immune cells are also considered to be asso- 
ciated with their differentiation and activation [22,23]. Gener- 
ally it is believed that pre-T cells undergo positive/negative 
selection in the thymus, resulting in the generation of functional 
CD4- or CD8-type T cells existing in the thymic medulla 
[24,25]. In this study, we focused on enzyme activity and rela- 
tive mRNA level of GM21GD2 synthase in developing thy- 
mocytes after treatment with two reagents which are considered 
to stimulate thymocytes through different signaling pathways 
[26,27]. The anti-CD3 mAb binds to the T cell receptor complex 
and triggers mature T cell activation and proliferation mimick- 
ing antigen stimulation via protein tyrosine kinases, a Ca*’ 
increase [28,29] and C kinase [30]. On the other hand, PGE2 
increases intracellular CAMP [31], which is reportedly produced 
in thymic stroma cells [32]. In NG108-15 cells, it quickly ele- 
vates GM2 synthase activity through phosphorylation of the 
relevant proteins by A kinase [33]. 
In order to analyze the regulation of ganglioside synthesis in 
mouse thymocytes under these conditions, mouse GM2/GD2 
synthase cDNAs were isolated. They showed very high homol- 
ogy with human homolog [lo], suggesting that this enzyme is 
required during development to maintain the structure, result- 
ing in the correct localization, high stability, substrate specific- 
ity and other properties. Using an obtained cDNA clone as a 
probe, alterations of the gene expression as well as the enzyme 
activity in mouse thymocytes were analyzed. 
Stimulations through CAMP and T cell receptor resulted in 
different responses in terms of GM2/GD2 synthase gene ex- 
pression and activity. Enzyme activity in thymocytes increased 
4 h after exposure to either reagent, whereas the mRNA level 
did not. The elevation of the enzyme activity at 4 h might be 
due to post-translational regulations, probably phosphoryla- 
tion of the enzyme itself or of relevant proteins as reported 
previously [34]. Actually, transient elevation of CAMP was con- 
firmed in thymocytes 30 min after exposure to PGE2 (data not 
shown). On the other hand, thymocytes treated with anti-CD3 
mAb showed increasing activity of GM2/GD2 synthase even 
at 24 h. It seemed to be associated with the increased mRNA 
level as shown in Fig. 4. In situ hybridization clearly demon- 
strated the actual increase of the mRNA level in the medullar 
thymocytes. This up-regulation of GM2/GD2 synthase mRNA 
after culture for 8-12 h with anti-CD3 mAb may occur via 
many cellular factors involved in T cell activation. Recently, 
Yoshimura et al. reported that cytotoxic T cells induced against 
FBL-3N leukemia expressed high levels of GD2 and GM21 
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GD2 synthase mRNA after repeated in vitro stimulation, but 
concanavalin A-treated lymphocytes did not [35]. Taken to- 
gether, T cell receptor-mediated signaling seems to be essential 
for the transcriptional regulation of GM21GD2 synthase gene 
in mature T cells. 
The significance of the up-regulation of GM21GD2 synthase 
in medullar thymocytes is unknown. The marked elevation of 
the mRNA level by anti-CD3 stimulation might result in a 
dynamic change of glycolipid expression on T cells, which may 
be associated with a functional property of the T cells. Changes 
of glycolipid profiles and their meanings remain to be investi- 
gated. 
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